Successful reactivation of hepatic Mrp transporters in endotoxininduced cholestasis in mice by the CAR activator 6,7-Dimethylesculetin

Size: px
Start display at page:

Download "Successful reactivation of hepatic Mrp transporters in endotoxininduced cholestasis in mice by the CAR activator 6,7-Dimethylesculetin"

Transcription

1 Successful reactivation of hepatic Mrp transporters in endotoxininduced cholestasis in mice by the activator 6,7-Dimethylesculetin Ina V. Martin *, Sebastian Voigt*, Michael Trauner, Christian Trautwein and Andreas Geier Dept. of Gastroenterology & Hepatology, University Hospital Aachen (UKA), Germany Division of Gastroenterology & Hepatology, Laboratory for Experimental Hepatology, University Hospital Zurich (USZ), Switzerland Falk Bile Acid Meeting Amsterdam, June 14th 2008

2 Hepatic organic anion transporters in obstructive cholestasis reduced maintained / increased Oatps MDR3/Mdr2 Mdr1 Mrp3 Mrp4 Pro-cholestatic (causal) Anti-cholestatic (adaptive)

3 Hepatic organic anion transporters in inflammatory cholestasis reduced maintained / increased LPS Oatps MDR3/Mdr2 Mdr1 Mrp3 Mrp4 Pro-cholestatic (causal) Anti-cholestatic (adaptive)

4 Hepatic organic anion transporters in inflammatory cholestasis LPS Shuttling of nuclear receptors IL-6 TNFα Il-1β IL-1β Oatp1 Mdr2 Mdr1 Mrp3 Mrp4 α nuclear protein CO 4h 8h 16h kd TNFα IL-1β 60 Siewert BBRC 2004 Geier Am J Physiol 2005 Ghose Nuclear Receptors 2004

5 Regulation of hepatic transport systems by nuclear receptors Mrp4 Mrp3 Activators as targets for intervention Oatp1 Oatp2 Oatp4 HNF4 HNF1 - RAR Stat5 HNF1 HNF1 HNF1 RAR SHP - FXR RAR FXR RAR FXR LRH-1 FXR TCPOBOP Phenobarbital 6,7-Dimethylesculetin PCN Atorvastatin Rifampicin GW4064 UDCA/TUDCA Geier Biochim Biophys Acta 2007 Karpen J Hepatology 2005

6 Induction of hepatic transport systems in healthy liver and CBDL Mrp4 Mrp3 Bili-Gluc -SO 2 Ugt1a1 TCPOBOP PB Sult2a1 PCN Atorvastatin Oatp1 Oatp2 Oatp4 Mrp3 Mrp4 Wagner Hepatology 2005

7 Induction of hepatic transport systems in inflammatory cholestasis Mrp3 30% RAR? Rosiglitazone? FXR 31% IR-1 DR-2 Ghose J Hepatology 2007

8 Background & Aims Inflammatory cholestasis has been previously characterized as a result of reduced organic anion transporter expression mediated by a decreased expression and altered subcellular localization of class II nuclear hormone receptors (NHR). We hypothesized that treatment with the activator 6,7-dimethylesculetin (DE) in endotoxemic mice may induce expression and putatively a nuclear redistribution of NHR leading to a maintained transporter gene expression. 6,7-dimethylesculetin as the active substance of Yin Chin has been used in Asian traditional medicine to treat neonatal jaundice for centuries.

9 Yin Chin (6,7-Dimethylesculetin) enhances bilirubin clearance by activating humanized transgenic mice YinChin/ 6,7-DE Artemisia capillaris Huang J Clin Invest 2004

10 Methods 6,7-DE or corn oil (Sham) C57/BL6 (25g; n=5) LPS Animal model - Inflammatory liver injury was induced in male C57/BL6 mice by intraperitoneal injection of endotoxin (0,5 mg/kg). - Intervention: Simultaneous application of 6,7- Dimethylesculetin (Sigma; 100 mg/kg) or corn oil only by i.p. injection. Livers were harvested after 4h and 16h h mrna Expression (RT-PCR, Northern) - hepatic transporters (,, -4) - nuclear receptors (,, FXR, RAR,, Lrh-1) -cytokines(tnfα, IL-1β) immunohistochemistry in fixed liver sections

11 Results & Conclusions (Abstract) Treatment with the activator 6,7-DE in endotoxemia induces NHR gene expression with maximum effects on and Lrh-1 RNA at 16 hours compared to an extensive suppression in control mice. Immunohistochemistry staining provided no definite DE-specific effect on localization, since sham controls were also characterized by a partial nuclear redistribution of the receptor protein. At 16h transcriptional and Lrh-1 activation was associated with a prominent induction of Mrp3 and a maintained expression of (and ) compared to a substantial decrease in controls. This study provides a potential protective interventional approach to selectively modify an otherwise unselective negative hepatic acute phase response during endotoxemia at the molecular level.

12 Hypothesis: targeting in inflammatory cholestasis Mrp4 Mrp3?? LRH-1 LRH-1 6,7-DE Mrp3 TNFα Il-1β IL-1β?

13 Acknowledgements Christoph Dietrich, Aschaffenburg Carsten Gartung, Minden Ina V. Martin Sebastian Voigt Hella Scotland Anne Porn Ann-Kathrin Vehr Alexander Minkenberg Joba Arikkat Sonja Strauch Michael Trauner, Graz Peter Mertens, Aachen Frank Lammert, Bonn Steven Dooley, Mannheim Elke Roeb, Giessen Bruno Stieger, Zürich Gerd Kullak-Ublick, Zürich M. Ananthanarayanan, New York

Hepatic Transporter Proteins involved in Bile Formation

Hepatic Transporter Proteins involved in Bile Formation Bile salt synthesis Hepatic Transporter Proteins involved in Bile Formation Basolateral membrane transporter proteins fx: NTCP uptake of bile salts OATP bulky organic anions Canalicular membrane transporter

More information

Cholestasis leads to hepatic and systemic accumulation

Cholestasis leads to hepatic and systemic accumulation CAR and PXR Agonists Stimulate Hepatic Bile Acid and Bilirubin Detoxification and Elimination Pathways in Mice Martin Wagner, 1 Emina Halilbasic, 1 Hanns-Ulrich Marschall, 2 Gernot Zollner, 1 Peter Fickert,

More information

The regulation of genes that are essential to many

The regulation of genes that are essential to many GASTROENTEROLOGY 2005;129:735 740 NEW CONCEPTS IN GASTROENTEROLOGY Nuclear Receptor Ligands: Rational and Effective Therapy for Chronic Cholestatic Liver Disease? JAMES L. BOYER Liver Center, Department

More information

Organic solute transporter alpha-beta (Ost -

Organic solute transporter alpha-beta (Ost - Mouse Organic Solute Transporter Deficiency Enhances Renal Excretion of Bile Acids and Attenuates Cholestasis Carol J. Soroka, 1 Albert Mennone, 1 Lee R. Hagey, 2 Nazzareno Ballatori, 3 and James L. Boyer

More information

Bile Acids and Liver Fibrosis Causative Agent and Therapeutic Tool

Bile Acids and Liver Fibrosis Causative Agent and Therapeutic Tool Bile Acids and Liver Fibrosis Causative Agent and Therapeutic Tool Peter Fickert, Andrea Fuchsbichler, Tarek Moustafa, Gernot Zollner, Emina Halilbasic, Ulrike Stöger, Cord Langner, Helmut Denk, and Michael

More information

Because they are potent detergents, synthesis of bile

Because they are potent detergents, synthesis of bile High Expression of the Bile Salt-Homeostatic Hormone Fibroblast Growth Factor 19 in the Liver of Patients with Extrahepatic Cholestasis Frank G. Schaap, 1 Niels A. van der Gaag, 2 Dirk J. Gouma, 2 and

More information

REVIEW Nuclear receptors as therapeutic targets in cholestatic liver diseases

REVIEW Nuclear receptors as therapeutic targets in cholestatic liver diseases British Journal of Pharmacology (2009), 156, 7 27 2008 The Authors Journal compilation 2008 The British Pharmacological Society All rights reserved 0007-1188/08 www.brjpharmacol.org REVIEW Nuclear receptors

More information

Falk Symposium 156: Genetics in Liver Disease. Pharmacogenetics. Gerd Kullak-Ublick

Falk Symposium 156: Genetics in Liver Disease. Pharmacogenetics. Gerd Kullak-Ublick Falk Symposium 156: Genetics in Liver Disease Pharmacogenetics Gerd Kullak-Ublick Division of Clinical Pharmacology and Toxicology Department of Internal Medicine University Hospital Zurich Freiburg, 8.

More information

Fasting induces basolateral uptake transporters of the SLC family in the liver via HNF4 and PGC1

Fasting induces basolateral uptake transporters of the SLC family in the liver via HNF4 and PGC1 Page 1 of 28 Articles in PresS. Am J Physiol Gastrointest Liver Physiol (July 19, 2007). doi:10.1152/ajpgi.00175.2007 Fasting induces basolateral uptake transporters of the SLC family in the liver via

More information

Inhibition of Human Hepatic Bile Acid Transporters as Contributing Factors to Drug-Induced Liver Injury

Inhibition of Human Hepatic Bile Acid Transporters as Contributing Factors to Drug-Induced Liver Injury Inhibition of Human Hepatic Bile Acid Transporters as Contributing Factors to Drug-Induced Liver Injury Kenneth R. Brouwer, Ph.D., RPh Chief Scientific Officer DDI Meeting June 2017 Seattle, Washington

More information

The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism

The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism Supplementary Information The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism Address correspondence to Yong Li (yongli@xmu.edu.cn, Tel: 86-592-218151) GW464 CDCA Supplementary

More information

Regulation of the cell surface expression and transport capacity of BSEP by small chemical molecules

Regulation of the cell surface expression and transport capacity of BSEP by small chemical molecules Regulation of the cell surface expression and transport capacity of by small chemical molecules Hisamitsu Hayashi and Yuichi Sugiyama Dept. of Molecular Pharmacokinetics, Graduate School of Pharmaceutical

More information

Genetic cholestasis. Peter Jansen Liver Center Academic Medical Center Amsterdam

Genetic cholestasis. Peter Jansen Liver Center Academic Medical Center Amsterdam Genetic cholestasis Peter Jansen Liver Center Academic Medical Center Amsterdam Genetic cholestasis Proteins and genes Genetic cholestatic diseases Lessons from ko/mutant models A new MDR3 phenotype A

More information

Pathophysiology of Bile Secretion

Pathophysiology of Bile Secretion Pathophysiology of Bile Secretion Martin C. Carey, D.Sc., M.D. Division of Gastroenterology, Brigham and Women s Hospital and Department of Medicine, Harvard Medical School Boston, MA, U.S.A. Functions

More information

The role of protein synthesis and degradation in the posttranscriptional regulation of rat multidrug resistance-associated protein 2 (Mrp2, Abcc2)

The role of protein synthesis and degradation in the posttranscriptional regulation of rat multidrug resistance-associated protein 2 (Mrp2, Abcc2) Molecular Pharmacology This article has Fast not been Forward. copyedited Published and formatted. The on final May version 25, 2005 may differ as doi:10.1124/mol.105.013144 from this version. The role

More information

Plasma exposure levels from individual mice 4 hours post IP administration at the

Plasma exposure levels from individual mice 4 hours post IP administration at the Supplemental Figure Legends Figure S1. Plasma exposure levels of MKC-3946 in mice. Plasma exposure levels from individual mice 4 hours post IP administration at the indicated dose mg/kg. Data represent

More information

Farnesoid X receptor represses hepatic human APOA gene expression

Farnesoid X receptor represses hepatic human APOA gene expression Research article Farnesoid X receptor represses hepatic human APOA gene expression Indumathi Chennamsetty, 1 Thierry Claudel, 2 Karam M. Kostner, 3 Anna Baghdasaryan, 2 Dagmar Kratky, 1 Sanja Levak-Frank,

More information

Constitutive Regulation of P450s by Endocrine Factors

Constitutive Regulation of P450s by Endocrine Factors References: Constitutive Regulation of P450s by Endocrine Factors Meyer UA. Endo-xenobiotic crosstalk and the regulation of cytochromes P450. Drug Metab Rev 39:639-46, 2007. Waxman DJ and O Connor C. Growth

More information

Multidrug resistance associated protein 4 (MRP4)

Multidrug resistance associated protein 4 (MRP4) Mrp4 / Mice Have an Impaired Cytoprotective Response in Obstructive Cholestasis Albert Mennone, 1 Carol J. Soroka, 1 Shi-Ying Cai, 1 Kathy Harry, 1 Masashi Adachi, 2 Lee Hagey, 3 John D. Schuetz, 2 and

More information

contributes to reversal of biliary fibrosis by Popov et al.

contributes to reversal of biliary fibrosis by Popov et al. Supplementary data to MS Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of biliary fibrosis by Popov et al. Supplementary table 1. Primers and probes used in quantitative

More information

Citation for published version (APA): Plass, J. R. M. (2005). Function and regulation of the human bile salt export pump Groningen: s.n.

Citation for published version (APA): Plass, J. R. M. (2005). Function and regulation of the human bile salt export pump Groningen: s.n. University of Groningen Function and regulation of the human bile salt export pump Plass, Jacqueline Regina Maria IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if

More information

Xingguo Cheng, Jonathan Maher, Matthew Z. Dieter, and Curtis D. Klaassen

Xingguo Cheng, Jonathan Maher, Matthew Z. Dieter, and Curtis D. Klaassen 0090-9556/05/3309-1276 1282$20.00 DRUG METABOLISM AND DISPOSITION Vol. 33, No. 9 Copyright 2005 by The American Society for Pharmacology and Experimental Therapeutics 3988/3045816 DMD 33:1276 1282, 2005

More information

In vivo dynamic metabolic imaging of obstructive cholestasis in mice

In vivo dynamic metabolic imaging of obstructive cholestasis in mice Am J Physiol Gastrointest Liver Physiol 296: G1091 G1097, 2009. First published February 26, 2009; doi:10.1152/ajpgi.90681.2008. In vivo dynamic metabolic imaging of obstructive cholestasis in mice Feng-Chieh

More information

DMD Fast Forward. Published on December 15, 2008 as DOI: /dmd DMD #

DMD Fast Forward. Published on December 15, 2008 as DOI: /dmd DMD # DMD Fast This Forward. article has not Published been copyedited on and December formatted. The 15, final 2008 version as may doi:10.1124/dmd.108.023630 differ from this version. DMD #23630 1 Regulation

More information

The Role of Protein Synthesis and Degradation in the Post- Transcriptional Regulation of Rat Multidrug Resistance- Associated Protein 2 (Mrp2, Abcc2)

The Role of Protein Synthesis and Degradation in the Post- Transcriptional Regulation of Rat Multidrug Resistance- Associated Protein 2 (Mrp2, Abcc2) 0026-895X/05/6803-701 710$20.00 MOLECULAR PHARMACOLOGY Vol. 68, No. 3 Copyright 2005 The American Society for Pharmacology and Experimental Therapeutics 13144/3045720 Mol Pharmacol 68:701 710, 2005 Printed

More information

Cholestatic liver dysfunction during critical illness

Cholestatic liver dysfunction during critical illness Cholestatic liver dysfunction during critical illness Yoo-Mee Vanwijngaerden Lies Langouche Dieter Mesotten Greet Van den Berghe Department of Cellular and Molecular Medicine Laboratory of Intensive Care

More information

Elevated copper impairs hepatic nuclear receptor function in Wilson s disease

Elevated copper impairs hepatic nuclear receptor function in Wilson s disease The Journal of Clinical Investigation Research article Elevated copper impairs hepatic nuclear receptor function in Wilson s disease Clavia Ruth Wooton-Kee, 1 Ajay K. Jain, 2 Martin Wagner, 3 Michael A.

More information

PUBLICATIONS. cells. J. Physiol. (London) 517P:91P (Manchester, England, UK).

PUBLICATIONS. cells. J. Physiol. (London) 517P:91P (Manchester, England, UK). 277 PUBLICATIONS Abstracts Haddad JJ, Land SC (1999). Differential activation of oxygen-responsive transcription factors over fetal-to-neonatal alveolar oxygen tensions in rat fetal distal lung epithelial

More information

Protective Effects of 6-Ethyl Chenodeoxycholic Acid, A. Cholestasis

Protective Effects of 6-Ethyl Chenodeoxycholic Acid, A. Cholestasis JPET Fast This article Forward. has not Published been copyedited on and January formatted. 11, The final 2005 version as DOI:10.1124/jpet.104.079665 may differ from this version. JPET#79665 1 Protective

More information

A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR

A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR Wendong Huang, Jun Zhang, and David D. Moore Department of Molecular and Cellular Biology, Baylor College

More information

Cholestatic Expression Pattern of Sinusoidal and Canalicular Organic Anion Transport Systems in Primary Cultured Rat Hepatocytes

Cholestatic Expression Pattern of Sinusoidal and Canalicular Organic Anion Transport Systems in Primary Cultured Rat Hepatocytes Original Articles Cholestatic Expression Pattern of Sinusoidal and Canalicular Organic Anion Transport Systems in Primary Cultured Rat Hepatocytes S. JANE RIPPIN, BRUNO HAGENBUCH, PETER J. MEIER, AND BRUNO

More information

Role of nuclear bile acid receptor FXR in intestinal bacterial overgrowth and translocation

Role of nuclear bile acid receptor FXR in intestinal bacterial overgrowth and translocation Role of nuclear bile acid receptor FXR in intestinal bacterial overgrowth and translocation Antonio Moschetta University of Bari, Consorzio Mario Negri Sud, Santa Maria Imbaro (Chieti), Italy www.negrisud.it

More information

Management of cholestatic diseases Today and tomorrow

Management of cholestatic diseases Today and tomorrow 12th Paris Hepatology Conference Management of cholestatic diseases Today and tomorrow Paris 15 January 2019 U. Beuers Department of Gastroenterology & Hepatology Tytgat Institute for Liver and Intestinal

More information

A shift in paradigm towards human biologybased systems for cholestatic-liver disease

A shift in paradigm towards human biologybased systems for cholestatic-liver disease A shift in paradigm towards human biologybased systems for cholestatic-liver disease Fozia Noor Systems Toxicology In Vitro Metabolomics Biochemical Engineering Institute Saarland University, Germany BioMed21

More information

Effect of High-fat or High-glucose Diet on Obesity and Visceral Adipose Tissue in Mice

Effect of High-fat or High-glucose Diet on Obesity and Visceral Adipose Tissue in Mice ACTA ACADEMIAE MEDICINAE SINICAE 410011 0731-85295846 lixia2014@vip. 163. com 4 C57BL /6 20-1 mrna 20 P < 0. 05 O 20 P > 0. 05 M2 P < 0. 05-1 mrna P < 0. 05 P > 0. 05 R589. 2 DOI 10. 3881 /j. issn. 1000-503X.

More information

CAROL J. SOROKA, JOHN M. LEE, FRANCESCO AZZAROLI, AND JAMES L. BOYER

CAROL J. SOROKA, JOHN M. LEE, FRANCESCO AZZAROLI, AND JAMES L. BOYER Cellular Localization and Up-regulation of Multidrug Resistance Associated Protein 3 in Hepatocytes and Cholangiocytes During Obstructive Cholestasis in Rat Liver CAROL J. SOROKA, JOHN M. LEE, FRANCESCO

More information

Int J Clin Exp Med 2015;8(2): /ISSN: /IJCEM

Int J Clin Exp Med 2015;8(2): /ISSN: /IJCEM Int J Clin Exp Med 2015;8(2):1691-1702 www.ijcem.com /ISSN:1940-5901/IJCEM0004080 Original Article Oral administration of oleanolic acid, isolated from Swertia mussotii Franch, attenuates liver injury,

More information

Supplementary Figure 1.

Supplementary Figure 1. Supplementary Figure 1. Female Pro-ins2 -/- mice at 5-6 weeks of age were either inoculated i.p. with a single dose of CVB4 (1x10 5 PFU/mouse) or PBS and treated with αgalcer or control vehicle. On day

More information

IMO-8400, a novel TLR7, TLR8 and TLR9 antagonist, psoriasis

IMO-8400, a novel TLR7, TLR8 and TLR9 antagonist, psoriasis IMO-8400, a novel TLR7, TLR8 and TLR9 antagonist, inhibits disease development in mouse models of psoriasis Weiwen e Ja Jiang, Fu-Gang Zhu, Dong Yu, Ekambar R. Kandimalla, a a, Nicola La Monica, and Sudhir

More information

The many faces of MDR 3 deficiency

The many faces of MDR 3 deficiency The many faces of MDR 3 deficiency Relevance of canalicular membrane transporting proteins for human liver disease Peter LM Jansen and Marleen de Vree Academic Medical Center Amsterdam, The Netherlands

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi: 1.138/nature7221 Brown fat selective genes 12 1 Control Q-RT-PCR (% of Control) 8 6 4 2 Ntrk3 Cox7a1 Cox8b Cox5b ATPase b2 ATPase f1a1 Sirt3 ERRα Elovl3/Cig3 PPARα Zic1 Supplementary Figure S1. stimulates

More information

Bile acid receptor FXR: metabolic regulator in the gut. Sungsoon Fang

Bile acid receptor FXR: metabolic regulator in the gut. Sungsoon Fang Bile acid receptor FXR: metabolic regulator in the gut Sungsoon Fang Nuclear hormone receptor 1905: Ernest Starling coined hormone 1929: Estrogen structure 1958: Estrogen receptor by Elwood Jensen 1985:

More information

Activation of Bile Acid Signaling Shapes the Gut Microbiota to Improve Diabetes and Fatty Liver Disease

Activation of Bile Acid Signaling Shapes the Gut Microbiota to Improve Diabetes and Fatty Liver Disease Activation of Bile Acid Signaling Shapes the Gut Microbiota to Improve Diabetes and Fatty Liver Disease John Chiang, Ph.D. Northeast Ohio Medical University Rootstown, OH, USA International Conference

More information

Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis. is mediated by SOCS3 regulatory pathway

Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis. is mediated by SOCS3 regulatory pathway Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway Yuan Zhang 1,2, Xing Li 1,2, Bogoljub Ciric 1, Cun-gen Ma 3, Bruno Gran 4, Abdolmohamad

More information

Supplemental Figures: Supplemental Figure 1

Supplemental Figures: Supplemental Figure 1 Supplemental Figures: Supplemental Figure 1 Suppl. Figure 1. BM-DC infection with H. pylori does not induce cytotoxicity and treatment of BM-DCs with H. pylori sonicate, but not heat-inactivated bacteria,

More information

General Laboratory methods Plasma analysis: Gene Expression Analysis: Immunoblot analysis: Immunohistochemistry:

General Laboratory methods Plasma analysis: Gene Expression Analysis: Immunoblot analysis: Immunohistochemistry: General Laboratory methods Plasma analysis: Plasma insulin (Mercodia, Sweden), leptin (duoset, R&D Systems Europe, Abingdon, United Kingdom), IL-6, TNFα and adiponectin levels (Quantikine kits, R&D Systems

More information

Drug-induced liver injury

Drug-induced liver injury Drug-induced liver injury Vincent Wong MBChB(Hons), MD, FRCP, FHKCP, FHKAM Professor, Department of Medicine and Therapeutics Director, Cheng Suen Man Shook Foundation Centre for Hepatitis Studies Deputy

More information

Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis

Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis Yaping Liu, 1 Jane Binz, 2 Mary Jo Numerick, 3 Steve Dennis, 3 Guizhen Luo, 1 Bhasha Desai,

More information

Bile acids initiate cholestatic liver injury by triggering a hepatic specific inflammatory response. Supplementary Results

Bile acids initiate cholestatic liver injury by triggering a hepatic specific inflammatory response. Supplementary Results Bile acids initiate cholestatic liver injury by triggering a hepatic specific inflammatory response Shi-Ying Cai 1, Xinshou Ouyang 1, Yonglin Chen 1, Carol J. Soroka 1, Juxian Wang 2, Albert Mennone 1,

More information

Supplemental Table 1: Demographics and characteristics of study participants. Male, n (%) 3 (20%) 6 (50%) Age, years [mean ± SD] 33.3 ± ± 9.

Supplemental Table 1: Demographics and characteristics of study participants. Male, n (%) 3 (20%) 6 (50%) Age, years [mean ± SD] 33.3 ± ± 9. SUPPLEMENTAL DATA Supplemental Table 1: Demographics and characteristics of study participants Lean (n=15) Obese (n=12) Male, n (%) 3 (20%) 6 (50%) Age, years [mean ± SD] 33.3 ± 9.5 44.8 ± 9.1 White, n

More information

Effect of BD Matrigel Matrix Overlay and BD Matrigel Matrix Thin Coat on CYP450 Activities in Cryo Human Hepatocytes. Rongjun Zuo.

Effect of BD Matrigel Matrix Overlay and BD Matrigel Matrix Thin Coat on CYP450 Activities in Cryo Human Hepatocytes. Rongjun Zuo. Effect of BD Matrigel Matrix Overlay and BD Matrigel Matrix Thin Coat on CYP450 Activities in Cryo Human Hepatocytes Rongjun Zuo November 10, 2010 Topics Overview of Hepatocyte Products P450 Induction

More information

CHAPTER 5 RESULTS Previous study: cell culture and organotypical slices

CHAPTER 5 RESULTS Previous study: cell culture and organotypical slices 45 CHAPTER 5 RESULTS 5.1. Previous study: cell culture and organotypical slices Initial experiments have been conducted to ensure that the tet-on system works. A neuronal cell culture from mice expressing

More information

Constitutive Regulation of P450s by Endocrine Factors

Constitutive Regulation of P450s by Endocrine Factors Constitutive Regulation of P450s by Endocrine Factors References: Meyer UA. Endo-xenobiotic crosstalk and the regulation of cytochromes P450. Drug Metab Rev 39:639-46, 2007. Waxman DJ and O Connor C. Growth

More information

Supplementary Information

Supplementary Information Supplementary Information TABLE S1. SUBJECT CHARACTERISTICS* Normal Control Subjects Subjects with Asthma p Value Number 23 48 Age (years) 35±10 35±10 0.75 Sex, M:F (% F) 9:12 (57) 17:26 (60) 0.76 FEV1

More information

Fxr -/- Mice Adapt to Biliary Obstruction by Enhanced Phase I Detoxification. and Renal Elimination of Bile Acids

Fxr -/- Mice Adapt to Biliary Obstruction by Enhanced Phase I Detoxification. and Renal Elimination of Bile Acids Fxr -/- Mice Adapt to Biliary Obstruction by Enhanced Phase I Detoxification and Renal Elimination of Bile Acids Hanns-Ulrich Marschall 1*, Martin Wagner 2, Karl Bodin 3, Gernot Zollner 2, Peter Fickert

More information

PCEUT 527 Enzyme Induction: Biochemical Mechanisms 2/13/15

PCEUT 527 Enzyme Induction: Biochemical Mechanisms 2/13/15 PCEUT 527 Enzyme Induction: Biochemical Mechanisms 2/13/15 1. General Principles 2. Increase in enzyme content through transcription 3. Protein degradation 4. Protein stabilization Why Does Induction Occur?

More information

Treatment of Chronic Cholestasis: What We Know and What We Will Know?

Treatment of Chronic Cholestasis: What We Know and What We Will Know? REVIEW Treatment of Chronic Cholestasis: What We Know and What We Will Know? James L. Boyer HISTORICAL PERSPECTIVES For many years, the treatment of cholestatic liver disease was limited to surgical relief

More information

British Liver Transplant Group Pathology meeting September Leeds cases

British Liver Transplant Group Pathology meeting September Leeds cases British Liver Transplant Group Pathology meeting September 2014 Leeds cases Leeds Case 1 Male 61 years Liver transplant for HCV cirrhosis with HCC in January 2014. Now raised ALT and bilirubin,? acute

More information

Supplementary fig. 1. Crystals induce necroptosis does not involve caspases, TNF receptor or NLRP3. A. Mouse tubular epithelial cells were pretreated

Supplementary fig. 1. Crystals induce necroptosis does not involve caspases, TNF receptor or NLRP3. A. Mouse tubular epithelial cells were pretreated Supplementary fig. 1. Crystals induce necroptosis does not involve caspases, TNF receptor or NLRP3. A. Mouse tubular epithelial cells were pretreated with zvad-fmk (10µM) and exposed to calcium oxalate

More information

Inclusion/Exclusion Criteria

Inclusion/Exclusion Criteria The Immunomodulatory Effects of Intensification among ART-suppressed Patients with Incomplete CD4 Recovery Peter W. Hunt, Nancy Shulman, Tim Hayes, Viktor Dahl, Ma Somsouk, Nick Funderburg, Alan L. Landay,

More information

Department of Internal Medicine and the Department of Pathology. Wake Forest University

Department of Internal Medicine and the Department of Pathology. Wake Forest University Bile Acid Transporters Paul A. Dawson, Tian Lan, Anuradha Rao Department of Internal Medicine and the Department of Pathology. Wake Forest University School of Medicine. Winston-Salem, NC 27157 Corresponding

More information

Supplemental Materials for. Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to. FTY720 during neuroinflammation

Supplemental Materials for. Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to. FTY720 during neuroinflammation Supplemental Materials for Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to FTY7 during neuroinflammation This file includes: Supplemental Table 1. EAE clinical parameters of

More information

Supplementary Figure 1. Expression of CUGBP1 in non-parenchymal liver cells treated with TGF-β

Supplementary Figure 1. Expression of CUGBP1 in non-parenchymal liver cells treated with TGF-β Supplementary Figures Supplementary Figure 1. Expression of CUGBP1 in non-parenchymal liver cells treated with TGF-β and LPS. Non-parenchymal liver cells were isolated and treated with or without TGF-β

More information

Nature Medicine: doi: /nm.4324

Nature Medicine: doi: /nm.4324 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Supplementary Figure 1. Kinetics of SnCs development in surgically-induced OA and effect of GCV-induced SnC clearance on OA disease progression

More information

Understanding the molecular actions of bile acid receptor activation for treating human liver disease

Understanding the molecular actions of bile acid receptor activation for treating human liver disease Understanding the molecular actions of bile acid receptor activation for treating human liver disease Purpose and aims The interplay between the liver, the gastrointestinal tract and lipid metabolism is

More information

Figure S1 Generation of γ-gt DTR transgenic mice. (A) Schematic construct of the transgene. (B)

Figure S1 Generation of γ-gt DTR transgenic mice. (A) Schematic construct of the transgene. (B) Figure S1 Generation of γ-gt DTR transgenic mice. (A) Schematic construct of the transgene. (B) PCR identified expected hhb-egf band (left panel) and HA tag band (right) in kidneys of transgenic (TG) mice

More information

Annals of Hepatology 2005; 4(2): April-June: Concise Review

Annals of Hepatology 2005; 4(2): April-June: Concise Review Annals of Hepatology 2005; 4(2): April-June: 77-99 Concise Review Annals of Hepatology Transcriptional regulation of hepatobiliary transport systems in health and disease: Implications for a rationale

More information

Drug Induced Liver Disease Role of the Pathologist. Disclosure. DILI can never be excluded. Romil Saxena, MD. Dr. Saxena has nothing to Disclose

Drug Induced Liver Disease Role of the Pathologist. Disclosure. DILI can never be excluded. Romil Saxena, MD. Dr. Saxena has nothing to Disclose Drug Induced Liver Disease Role of the Pathologist Romil Saxena, MD Disclosure Dr. Saxena has nothing to Disclose DILI can never be excluded #1 DILI has no specific pattern of injury it can mimic any and

More information

Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel

Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel Supplementary Figures 1-8 Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel Marc Schmidt 1,2, Badrinarayanan Raghavan 1,2, Verena Müller 1,2, Thomas Vogl 3, György

More information

Role of metabolism in Drug-Induced Liver Injury (DILI) Drug Metab Rev. 2007;39(1):

Role of metabolism in Drug-Induced Liver Injury (DILI) Drug Metab Rev. 2007;39(1): Role of metabolism in Drug-Induced Liver Injury (DILI) Drug Metab Rev. 2007;39(1):159-234 Drug Metab Rev. 2007;39(1):159-234 Drug Metab Rev. 2007;39(1):159-234 A schematic representation of the most relevant

More information

Viral Load-Dependent Effects of Liver Injury and Regeneration on HBV. Replication in Mice

Viral Load-Dependent Effects of Liver Injury and Regeneration on HBV. Replication in Mice JVI Accepts, published online ahead of print on 20 June 2012 J. Virol. doi:10.1128/jvi.01087-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10 11 12 13 14

More information

Hepatotoxicity: A Drug-Induced Cholestatic Pattern

Hepatotoxicity: A Drug-Induced Cholestatic Pattern Review articles Laura Morales M., 1 Natalia Vélez L., 1 Octavio Germán Muñoz M., MD. 2 1 Medical Student in the Faculty of Medicine and the Gastrohepatology Group at the Universidad de Antioquia in Medellín,

More information

Role of Farnesoid X Receptor in the Determination of. Liver Transcriptome during Postnatal Maturation in

Role of Farnesoid X Receptor in the Determination of. Liver Transcriptome during Postnatal Maturation in Role of Farnesoid X Receptor in the Determination of Liver Transcriptome during Postnatal Maturation in Mice Lai Peng 1, Stephanie Piekos 1, Grace L. Guo 2, and Xiao-bo Zhong 1 1 Department of Pharmaceutical

More information

Regulation of P450. b. competitive-inhibitor but not substrate. c. non-competitive inhibition. 2. Covalent binding to heme or protein

Regulation of P450. b. competitive-inhibitor but not substrate. c. non-competitive inhibition. 2. Covalent binding to heme or protein 10. Inhibition of P450 Regulation of P450 a. competitive-2 chemicals metabolized by same isoform b. competitive-inhibitor but not substrate c. non-competitive inhibition 11. Induction of P450 1. Non-covalent

More information

The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23- induced production of the cytokine GM-CSF

The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23- induced production of the cytokine GM-CSF CORRECTION NOTICE Nat.Immunol. 12, 568 575 (2011) The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23- induced production of the cytokine GM-CSF Mohamed El-Behi, Bogoljub Ciric, Hong

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION 1. Supplementary Figures and Legends Supplementary Fig. 1. S1P-mediated transcriptional regulation of integrins expressed in OP/monocytoid cells. Real-time quantitative PCR analyses of mrna for two integrins,

More information

Prolonged cholestasis triggered by hepatitis A virus infection and variants of the hepatocanalicular phospholipid and bile salt transporters

Prolonged cholestasis triggered by hepatitis A virus infection and variants of the hepatocanalicular phospholipid and bile salt transporters 710 CASE REPORT September-October, Vol. 11 No.5, 2012: 710-714 Prolonged cholestasis triggered by hepatitis A virus infection and variants of the hepatocanalicular phospholipid and bile salt transporters

More information

Part-I: Screening. 3.1 Assessment of non-toxic concentration of test compounds in RAW cells. Results

Part-I: Screening. 3.1 Assessment of non-toxic concentration of test compounds in RAW cells. Results Part-I: Screening Our strategy was to look for compounds which can inhibit HMGB1 (high mobility group box 1) release in activated macrophages and check effect of screened compound on endotoxemic mice.

More information

Alcoholic Hepatitis. Christian Doppler Research Laboratory for Gut Inflammation Medical University Innsbruck. Herbert Tilg

Alcoholic Hepatitis. Christian Doppler Research Laboratory for Gut Inflammation Medical University Innsbruck. Herbert Tilg Alcoholic Hepatitis Christian Doppler Research Laboratory for Gut Inflammation Medical University Innsbruck Herbert Tilg Overview Background I: Alcoholic steatohepatitis (ASH) is a severe and often life-threatening

More information

Assessment of inhibitory effect of many therapeutically important drugs on bile acid transport by NTCP, BSEP and other transporters

Assessment of inhibitory effect of many therapeutically important drugs on bile acid transport by NTCP, BSEP and other transporters ct 6, 26 Falk Symposium 155; XIX International Bile Acid Meeting Assessment of inhibitory effect of many therapeutically important drugs on bile acid transport by NTCP, BSEP and other transporters Kazuya

More information

Interface hepatitis in PBC: Prognostic marker and therapeutic target

Interface hepatitis in PBC: Prognostic marker and therapeutic target Interface hepatitis in PBC: Prognostic marker and therapeutic target Raoul Poupon Service d Hépatologie, Hôpital Saint-Antoine, Paris Faculté de Médecine Pierre & Marie Curie, Paris Key features of

More information

In vivo effect of anti-inflammatory compounds on HIV-1 gp120 -mediated brain inflammation

In vivo effect of anti-inflammatory compounds on HIV-1 gp120 -mediated brain inflammation In vivo effect of anti-inflammatory compounds on HIV-1 gp120 -mediated brain inflammation Tamima Ashraf, PhD candidate Supervisor: Dr. Reina Bendayan University of Toronto, Leslie Dan Faculty of Pharmacy,

More information

Identification of a new FXR target gene: fibrinogen Bβ

Identification of a new FXR target gene: fibrinogen Bβ Chapter 5 Identification of a new FXR target gene: fibrinogen Bβ Jacqueline R.M. Plass, Mariska Geuken, Janette Heegsma, Peter L.M. Jansen, and Klaas Nico Faber. Division of Gastroenterology and Hepatology,

More information

New recommendations for immunocompromised patients

New recommendations for immunocompromised patients New recommendations for immunocompromised patients Hepatitis E Virus (HEV): Transmission, incidence and presentation Emerging evidence regarding HEV transmission from blood components and dietary consumption

More information

Risk stratification in PBC

Risk stratification in PBC Risk stratification in PBC Christophe Corpechot Reference Center for Inflammatory Biliary Diseases Saint-Antoine hospital, Paris, France What is currently known (background) PBC : chronic, progressive

More information

Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas

Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas 0090-9556/04/3211-1265 1271$20.00 DRUG METABOLISM AND DISPOSITION Vol. 32, No. 11 Copyright 2004 by The American Society for Pharmacology and Experimental Therapeutics 1281/1178713 DMD 32:1265 1271, 2004

More information

Supplemental Table 1. Primers used for RT-PCR analysis of inflammatory cytokines Gene Primer Sequence

Supplemental Table 1. Primers used for RT-PCR analysis of inflammatory cytokines Gene Primer Sequence Supplemental Table 1. Primers used for RT-PCR analysis of inflammatory cytokines Gene Primer Sequence IL-1α Forward primer 5 -CAAGATGGCCAAAGTTCGTGAC-3' Reverse primer 5 -GTCTCATGAAGTGAGCCATAGC-3 IL-1β

More information

Kupffer cell depletion with liposomal clodronate prevents suppression of Ntcp expression in endotoxin-treated rats

Kupffer cell depletion with liposomal clodronate prevents suppression of Ntcp expression in endotoxin-treated rats Journal of Hepatology 42 (2005) 102 109 www.elsevier.com/locate/jhep Kupffer cell depletion with liposomal clodronate prevents suppression of Ntcp expression in endotoxin-treated rats Ekkehard Sturm 1,

More information

MicroRNAs Modulate the Noncanonical NF- B Pathway by Regulating IKK Expression During Macrophage Differentiation

MicroRNAs Modulate the Noncanonical NF- B Pathway by Regulating IKK Expression During Macrophage Differentiation MicroRNAs Modulate the Noncanonical NF- B Pathway by Regulating IKK Expression During Macrophage Differentiation Tao Li 1 *, Michael J. Morgan 1 *, Swati Choksi 1, Yan Zhang 1, You-Sun Kim 2#, Zheng-gang

More information

BSEP inhibition and Drug Induced Liver Injury

BSEP inhibition and Drug Induced Liver Injury BSEP inhibition and Drug Induced Liver Injury Gerry Kenna Pharmaceutical Director, Safer Medicines Trust www.safermedicines.org Drug Safety Consultant Overview Drug Induced Liver Injury (DILI) BSEP inhibition

More information

Zurich Open Repository and Archive. Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy

Zurich Open Repository and Archive. Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy University of Zurich Zurich Open Repository and Archive Winterthurerstr. 190 CH-8057 Zurich http://www.zora.uzh.ch Year: 2010 Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis

More information

corn oil. The controls received an equivalent

corn oil. The controls received an equivalent Effect of 2,3,7,8-Tetrachlorodibenzo-p-dioxin on the Biliary Excretion of Indocyanine Green in Rat by Slang W1. Hwang* Chlorinated dibenzodioxins have been found as contaminants of various technical chlorinated

More information

University of Groningen. Non-anastomotic biliary strictures after liver transplantation Hoekstra, Harm

University of Groningen. Non-anastomotic biliary strictures after liver transplantation Hoekstra, Harm University of Groningen Non-anastomotic biliary strictures after liver transplantation Hoekstra, Harm IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to

More information

XV Jornada de Avances en Hepatología Málaga 20 y 21 de Mayo de Barrera intestinal en la cirrosis. Agustín Albillos

XV Jornada de Avances en Hepatología Málaga 20 y 21 de Mayo de Barrera intestinal en la cirrosis. Agustín Albillos XV Jornada de Avances en Hepatología Málaga 20 y 21 de Mayo de 2016 Barrera intestinal en la cirrosis Agustín Albillos Hospital Universitario Ramón y Cajal Universidad de Alcalá, Ciberehd Madrid, Spain

More information

Cholestasis: human disease and experimental animal models

Cholestasis: human disease and experimental animal models Annals of Hepatology 2003; 2(4): OctoberDecember: 150158 Concise Review Annals of Hepatology Cholestasis: human disease and experimental animal models Emilio Alberto RodríguezGaray, MD, PhD 1 Abstract

More information

PXR Prevents Cholesterol Gallstone Disease by Regulating Biosynthesis and Transport of Bile Salts

PXR Prevents Cholesterol Gallstone Disease by Regulating Biosynthesis and Transport of Bile Salts GASTROENTEROLOGY 2011;140:2095 2106 PXR Prevents Cholesterol Gallstone Disease by Regulating Biosynthesis and Transport of Bile Salts JINHAN HE,* SHIGERU NISHIDA, MEISHU XU,* MAKOTO MAKISHIMA, and WEN

More information

Supplementary Figure 1. Confocal immunofluorescence showing mitochondrial translocation of Drp1. Cardiomyocytes treated with H 2 O 2 were prestained

Supplementary Figure 1. Confocal immunofluorescence showing mitochondrial translocation of Drp1. Cardiomyocytes treated with H 2 O 2 were prestained Supplementary Figure 1. Confocal immunofluorescence showing mitochondrial translocation of Drp1. Cardiomyocytes treated with H 2 O 2 were prestained with MitoTracker (red), then were immunostained with

More information

EFFECT OF DEXAMETHASONE TREATMENT ON THE EXPRESSION AND FUNCTION OF TRANSPORT PROTEINS IN SANDWICH-CULTURED RAT HEPATOCYTES

EFFECT OF DEXAMETHASONE TREATMENT ON THE EXPRESSION AND FUNCTION OF TRANSPORT PROTEINS IN SANDWICH-CULTURED RAT HEPATOCYTES 0090-9556/04/3208-834 839$20.00 DRUG METABOLISM AND DISPOSITION Vol. 32, No. 8 Copyright 2004 by The American Society for Pharmacology and Experimental Therapeutics 1367/1167793 DMD 32:834 839, 2004 Printed

More information

OATP1B1 is a member of the organic anion. Liver X Receptor a and Farnesoid X Receptor Are Major Transcriptional Regulators of OATP1B1

OATP1B1 is a member of the organic anion. Liver X Receptor a and Farnesoid X Receptor Are Major Transcriptional Regulators of OATP1B1 LIVER BIOLOGY/PATHOBIOLOGY Liver X Receptor a and Farnesoid X Receptor Are Major Transcriptional Regulators of OATP1B1 Henriette E. Meyer zu Schwabedissen, 1,2 Kerstin Böttcher, 2 Amarjit Chaudhry, 3 Heyo

More information

Supplementary Figures for TSC1 controls macrophage polarization to prevent inflammatory disorder by Linnan Zhu et al

Supplementary Figures for TSC1 controls macrophage polarization to prevent inflammatory disorder by Linnan Zhu et al Supplementary Figures for TSC1 controls macrophage polarization to prevent inflammatory disorder by Linnan Zhu et al Suppl. Fig. 1 Tissue DN C Proteins kd TSC1-17 TSC 1 loxp bp -48-285 ctin PEMs Neutrophils

More information